264 related articles for article (PubMed ID: 24289627)
21. New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Zheng N; Pan C; Liu W
J Int Med Res; 2011; 39(4):1184-92. PubMed ID: 21986120
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.
Liao CC; Ward N; Marsh S; Arulampalam T; Norton JD
BMC Cancer; 2010 Aug; 10():410. PubMed ID: 20691062
[TBL] [Abstract][Full Text] [Related]
23. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
[TBL] [Abstract][Full Text] [Related]
24. Pituitary adenoma biomarkers identified using proteomic fingerprint technology.
Zhou KY; Jin HH; Bai ZQ; Liu CB
Asian Pac J Cancer Prev; 2012; 13(8):4093-5. PubMed ID: 23098522
[TBL] [Abstract][Full Text] [Related]
25. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
26. [MALDI-TOF-MS combined with WCX technique in diagnosing pituitary adenoma].
Zhou KY; Jin HH; Liu CB
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):477-80. PubMed ID: 24386833
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
[TBL] [Abstract][Full Text] [Related]
28. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
[TBL] [Abstract][Full Text] [Related]
30. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
31. Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS.
Sui W; Huang L; Dai Y; Chen J; Yan Q; Huang H
Clin Exp Med; 2010 Dec; 10(4):259-68. PubMed ID: 20376689
[TBL] [Abstract][Full Text] [Related]
32. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
33. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
34. [Classification and diagnostic prediction of colorectal cancer using protein profiling of serum and bioinformatics].
Chen YD; Xie PP; Yu JW; Zhou J; Zheng S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):470-7. PubMed ID: 19830859
[TBL] [Abstract][Full Text] [Related]
35. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
36. Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
Huijbers A; Mesker WE; Mertens BJ; Bladergroen MR; Deelder AM; van der Burgt YE; Tollenaar RA
Colorectal Dis; 2014 Nov; 16(11):907-13. PubMed ID: 25243779
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the raw serum peptidomic pattern in glioma patients.
Li Z; Lu H; Yang J; Zeng X; Zhao L; Li H; Liao Q; Peng S; Zhou M; Wu M; Xiang J; Wang Y; Li G
Clin Chim Acta; 2013 Oct; 425():221-6. PubMed ID: 23954773
[TBL] [Abstract][Full Text] [Related]
38. Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting.
Long L; Li R; Li Y; Hu C; Li Z
Rheumatol Int; 2011 Aug; 31(8):1069-74. PubMed ID: 20336460
[TBL] [Abstract][Full Text] [Related]
39. SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.
Qian JY; Mou SH; Liu CB
Asian Pac J Cancer Prev; 2012; 13(5):1911-5. PubMed ID: 22901146
[TBL] [Abstract][Full Text] [Related]
40. Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.
Wang Q; Shen J; Li ZF; Jie JZ; Wang WY; Wang J; Zhang ZT; Li ZX; Yan L; Gu J
BMC Cancer; 2009 Aug; 9():287. PubMed ID: 19689818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
